Concepedia

Ron Eydelloth

RE

Statistics

Publications

1

Citations

11

H-Index

1

Active since

2020

Affiliations

Mersana Therapeutics (United States)(Current)

Ron Eydelloth is an author at Mersana Therapeutics (United States) specializing in bioconjugation reagents, antibody-drug conjugates, and targeted cancer therapy.

Publications per year

2020–2020

1

Publications

1

Abstract 2894: XMT-1592, a site-specific Dolasynthen-based NaPi2b-targeted antibody-drug conjugate for the treatment of ovarian cancer and lung adenocarcinoma

Shawn P. Fessler, Anouk Dirksen, Scott D. Collins et al. · Cancer Research · 2020 · 11 citations

, , +16

1–1 of 1